Publications by authors named "A Cribier"
Background: Transcatheter (TAVR) has supplanted surgical (SAVR) aortic valve replacement (AVR).
Aim: To evaluate whether adoption of this technology has varied according to centre volume at the nationwide level.
Methods: From an administrative hospital-discharge database, we collected data on all AVRs performed in France between 2007 and 2019.
Research performed in Europe has driven cardiovascular device innovation. This includes, but is not limited to, percutaneous coronary intervention, cardiac imaging, transcatheter heart valve implantation, and device therapy of cardiac arrhythmias and heart failure. An important part of future medical progress involves the evolution of medical technology and the ongoing development of artificial intelligence and machine learning.
View Article and Find Full Text PDFBackground: The coronavirus disease of 2019 (COVID-19) pandemic lockdowns limited access to medical care. The impact on surgical (SAVR) and transcatheter (TAVR) aortic valve replacement (AVR) has been poorly described.
Aim: We sought to evaluate the impact of the COVID-19 pandemic on the number and modalities of AVR, patient demographics and in-hospital outcomes at the nationwide level.
Article Synopsis
- - The study examined trends in transcatheter aortic valve replacement (TAVR) usage in France from 2015 to 2020, focusing on how age and sex influence patient demographics and in-hospital outcomes.
- - Results showed that TAVR use among patients under 65 years increased significantly (by 63.2%), but it still accounted for only 11.1% of aortic valve replacements in this age group by 2020; TAVR was more commonly used in patients aged 65 and older.
- - Key findings revealed notable sex differences in demographics and outcomes: females were older, had lower comorbidity scores, were more likely to undergo TAVR, and experienced higher in